Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Accounting Policies [Abstract]

Schedules of Concentration of Risk, by Risk Factor

A significant customer is any biopharmaceutical customer, clinical testing payer, or international laboratory partner that represents 10% or more of the Company’s total revenue or accounts receivable balance. Revenue attributable to each significant customer, including its affiliated entities, as a percentage of the Company’s total revenue, for the respective period, and accounts receivable balance attributable to each significant customers, including its affiliated entities, as a percentage of the Company’s total accounts receivable balance, at the respective condensed consolidated balance sheet date, are as follows:

	Revenue				Accounts Receivable, Net
	Three Months Ended March 31,				March 31, 2024		December 31, 2023
	2024		2023
	(unaudited)				(unaudited)
Customer A	*		*		16	%	12	%
Customer B	31	%	31	%	12	%	12	%
Customer C	*		*		*		10	%

*    less than 10%